According to an announcement submitted to the Hong Kong Stock Exchange, Shenzhen Maiktian Biomedical Technology sold 38.9 million shares in Hong Kong at a price of HK$15.42 per share. According to calculations, the company plans to raise HK$600 million. The listing is expected to be traded on September 7. Morgan Stanley and Huatai International are co-sponsors.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.